Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Karmali, Reem
Associate Professor
Bio
My research focuses on associations between disorders of energy metabolism and lymphoma pathogenesis. Specifically, my research has been driven by the hypothesis that cachexia is a metabolically and ... [more]
Kelleher, Neil
Professor
Bio
Natural Products Discovery and Biosynthesis, Top Down Mass Spectrometry, and Epiproteomics.
Khan, Irum
Associate Professor
Bio
Dr. Khan's research is focused on translation studies in myeloid malignancies. She focuses on identifying and validating therapeutic targets in myeloid leukemias using patient samples and animal ... [more]
Kumthekar, Priya U.
Associate Professor
Bio
My interests include treating primary brain tumors such as gliomas and meningiomas. I also have a specific interest in metastatic disease to the brain from systemic cancers such as melanoma, lung and ... [more]
Lesniak, Maciej (Matt) S
Professor
Bio
My clinical and research interests focus on neurosurgical management of patients with brain and spinal cord tumors.
Lewandowski, Robert J.
Professor
Bio
I have collaborated in many pre-clinical and clinical research projects and published regularly on preclinical studies including the rabbit and rat tumor models, embolization procedures, and ... [more]
Li, Xiao-Nan
Professor
Bio
My goal is to develop humanized PDOX models to test new immunotherapies against pediatric malignant brain tumors and to understand the molecular biology that mediate the response and resistance of new... [more]
Lin, Adam
Assistant Professor
Bio
Dr. Lin is a hematologist and oncologist with a clinical focus on lymphoma, cellular therapies, and stem cell transplantation. He has extensive background in nanotechnology, biomaterials to bridge the... [more]
Liu, Yan
Associate Professor
Bio
Investigating the molecular mechanisms underlying clonal hematopoiesis of indeterminate potential (CHIP), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML)... [more]
Longnecker, Richard
Professor
Bio
Ultimately, studies by the Longnecker laboratory may provide insight for the development of novel therapeutics for the treatment of herpesvirus infections in humans and better understanding of the her... [more]